News Daily News It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions Jason Kahn March 06, 2012
Presentation TCT 2012 Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study. Presenter: Emmanouil S. Brilakis, Aristotelis C. Papayannis, Abdul-rahman R. Abdel-karim, Tesfaldet T. Michael, Arif Mahmood, Lorenza B. Makke, Michele Roesle, Donald Haagen, Bavana V. Rangan, Subhash Banerjee January 03, 2012
News Daily News Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents L.A. McKeown September 16, 2011
News Daily News ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions Jason Kahn September 12, 2011
News Daily News RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES L.A. McKeown June 10, 2011
News Conference News ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions Jason Kahn April 04, 2011
News Daily News Vascular Stents an Option for Some Patients with Fibrosing Mediastinitis March 29, 2011
News Daily News Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease Jason Kahn January 23, 2011